A detailed history of Cubist Systematic Strategies, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 303,718 shares of EW stock, worth $20.1 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
303,718
Previous 2,000 15085.9%
Holding current value
$20.1 Million
Previous $184,000 10792.39%
% of portfolio
0.13%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $18.1 Million - $28.5 Million
303,718 New
303,718 $20 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $20 Million - $27 Million
289,229 New
289,229 $20 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $17.7 Million - $20.1 Million
-237,776 Reduced 68.01%
111,818 $9.25 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $9.21 Million - $11.8 Million
134,830 Added 62.78%
349,594 $26.1 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $15.9 Million - $20.7 Million
192,902 Added 882.36%
214,764 $17.7 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $310,275 - $460,104
-3,587 Reduced 14.09%
21,862 $2.08 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $1.1 Million - $1.38 Million
10,768 Added 73.35%
25,449 $3 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $3.47 Million - $4.26 Million
-32,584 Reduced 68.94%
14,681 $1.9 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $2.74 Million - $3.27 Million
26,662 Added 129.41%
47,265 $5.35 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $3.51 Million - $4.38 Million
-41,812 Reduced 66.99%
20,603 $2.13 Million
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $3.26 Million - $3.75 Million
41,397 Added 196.96%
62,415 $5.22 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $13.5 Million - $17.1 Million
-187,690 Reduced 89.93%
21,018 $1.92 Million
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $3.01 Million - $3.92 Million
-44,810 Reduced 17.68%
208,708 $16.7 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $10.1 Million - $13.5 Million
174,850 Added 222.26%
253,518 $17.5 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $23,322 - $36,045
-445 Reduced 0.56%
78,668 $14.8 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $5.62 Million - $6.44 Million
78,429 Added 11466.23%
79,113 $18.5 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $4.07 Million - $4.99 Million
-66,138 Reduced 98.98%
684 $150,000
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $3.69 Million - $4.27 Million
66,236 Added 11303.07%
66,822 $12.3 Million
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $191,655 - $256,328
-4,002 Reduced 87.23%
586 $112,000
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $152,596 - $187,218
3,288 Added 252.92%
4,588 $703,000
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $28,928 - $36,732
-633 Reduced 32.75%
1,300 $226,000
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $32,983 - $39,860
-777 Reduced 28.67%
1,933 $281,000
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $233,032 - $297,321
-6,266 Reduced 69.81%
2,710 $378,000
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $1.75 Million - $2.04 Million
-51,826 Reduced 85.24%
8,976 $1.01 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $2.21 Million - $2.36 Million
60,802
60,802 $6.65 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.